Geopolitical risks can significantly reshape market access, disrupt operations, and drive costs up overnight. For businesses ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Susman shared Tuesday that she’ll be stepping down from her role as EVP and chief corporate affairs officer after 18 years with the company. Susman joined Pfizer in 2007 and helped lead the company ...

Departures: Top Pfizer communications executive Sally Susman is stepping down, effective at the end of the year. Linda Yaccarino resigned as CEO of X. Miscellaneous: Six major medical groups, and a ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years. Read more here.

Pfizer’s longtime corporate affairs chief, Sally Susman, will depart this year, the pharmaceutical giant announced Tuesday. Five executives will take on her work, CEO Albert Bourla explained, as ...

NEW YORK: Top Pfizer communications executive Sally Susman is stepping down, effective at the end of the year. The company does not plan to replace Susman as EVP and chief corporate affairs officer.

Explore daily insights on the USA TODAY crossword puzzle by Sally Hoelscher. Uncover expert takes and answers in our crossword blog.

The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the pharmaceutical company.

The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an allegation that clinical testing related to the development of the ...